These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 7403052)

  • 1. [Rifampicin and isoniazid concentration in the blood and resected lungs in tuberculosis with combined use of the preparations].
    Kislitsyna NA; Kotova NI
    Probl Tuberk; 1980 Aug; (8):63-5. PubMed ID: 7403052
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparative evaluation of rifampicin and isoniazid penetration into the pathological foci of the lungs in tuberculosis patients].
    Kislitsyna NA
    Probl Tuberk; 1985; (4):55-7. PubMed ID: 4001111
    [No Abstract]   [Full Text] [Related]  

  • 3. [Biotransformation of rifampicin in pulmonary tuberculosis patients].
    Ioffe RA
    Antibiotiki; 1977; 22(2):177-80. PubMed ID: 558736
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Isoniazid concentrations in the blood, resected lung tissue and the gallbladder bed in relation to the method of administration to pulmonary tuberculosis patients with stomach and liver diseases].
    Androsov EE; Vinokurov VA; Garvalinskiĭ GF; Karita VR; Pogrebinskiĭ MB
    Antibiotiki; 1984 Sep; 29(9):671-3. PubMed ID: 6508257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Pharmacokinetics of isoniazid, rifampicin and streptomycin in tuberculosis patients with chronic cor pulmonale].
    Petrenko VI
    Probl Tuberk; 1985; (10):34-7. PubMed ID: 4070202
    [No Abstract]   [Full Text] [Related]  

  • 7. [Concentration of rifampicin in pathological formations of resected lungs].
    Kislitsyna NA; Kotova NI
    Probl Tuberk; 1975; (6):79-81. PubMed ID: 1215358
    [No Abstract]   [Full Text] [Related]  

  • 8. [Pharmacokinetic characteristics of streptomycin and isoniazid administered in ultrasonic aerosols to patients with respiratory organ tuberculosis].
    Brant AL; Semenova EA
    Antibiotiki; 1981 Aug; 26(8):628-32. PubMed ID: 7294755
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Pyridoxine metabolism in pulmonary tuberculosis patients under rifampicin therapy in combination with isoniazid].
    Baĭramaliev G; Krasheninnikova MA; Kolosovskaia VP; Chukanov VI
    Probl Tuberk; 1982 Jan; (1):58-62. PubMed ID: 7058194
    [No Abstract]   [Full Text] [Related]  

  • 10. On the pharmacokinetics of rifampicin I: Influence of dosage and duration of treatment with intermittent administration.
    Iwainsky H; Winsel K; Werner E; Eule H
    Scand J Respir Dis; 1974; 55(4):229-36. PubMed ID: 4438983
    [No Abstract]   [Full Text] [Related]  

  • 11. [Isoniazid pharmacokinetics in the combined chemotherapy of tuberculosis].
    Sokolova GB; Vilenskaia RN; Ivleva AIa; Galenko NN; Ziia AV
    Probl Tuberk; 1981 Oct; (10):24-8. PubMed ID: 7312844
    [No Abstract]   [Full Text] [Related]  

  • 12. Studies on pharmacokinetics of rifampicin in the body of patients with pulmonary tuberculosis.
    Pawlowska I; Pniewski T
    Arzneimittelforschung; 1979; 29(12):1906-11. PubMed ID: 546432
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inoculation of Mycobacterium tuberculosis and INH concentration in resected lung tissue].
    Vinnik LA; Sutyrina GV; Boldyreva AA; Shevchenko AM
    Probl Tuberk; 1965; 43(1):75-8. PubMed ID: 4953508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Case of pulmonary multi-drug resistant tuberculosis with left destroyed lung, treated with pneumonectomy].
    Koyama K; Kawakami K; Harada Y; Yamaryo T; Kimura Y
    Kekkaku; 2007 Jul; 82(7):577-81. PubMed ID: 17695788
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Decomposition of INH and cycloserin preparations in the body of patients with tuberculosis of the lungs].
    Smirnov GA
    Probl Tuberk; 1977 Aug; (8):63-6. PubMed ID: 905277
    [No Abstract]   [Full Text] [Related]  

  • 16. [The validation of the adequacy of chemotherapy in bladder tuberculosis based on a study of bacteriostatic activity].
    Dovlatian AA; Dzhenzhera NA
    Probl Tuberk; 1992; (11-12):49-51. PubMed ID: 1289890
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation on the serum and lung tissue level of rifampicin in man.
    Kiss IJ; Faragó E; Juház I; Bacsa S; Fábián E
    Int J Clin Pharmacol Biopharm; 1976 Jan; 13(1):42-7. PubMed ID: 1248917
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of isoniazid-resistant tuberculosis with isoniazid, rifampin, ethambutol, and pyrazinamide for 6 months.
    Nolan CM; Goldberg SV
    Int J Tuberc Lung Dis; 2002 Nov; 6(11):952-8. PubMed ID: 12475140
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Pharmacokinetics and clinical importance of the interactions of rifampicin with phenprocoumone and isoniazide].
    von Oldershausen HF; Musch E; Rudolf G; Gieraths A; Schunter C
    Verh Dtsch Ges Inn Med; 1978; (84):1468-72. PubMed ID: 741993
    [No Abstract]   [Full Text] [Related]  

  • 20. [Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].
    Zierski M; Bek E
    Pneumonol Pol; 1980 Jul; 48(7):469-79. PubMed ID: 7433146
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.